The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells

Microtubule-stabilizing agents: New drug discovery and cancer therapy

(2016) Ying Zhao et al.   PHARMACOLOGY & THERAPEUTICS

Treatment regimens of classical and newer taxanes

(2015) Markus Joerger   CANCER CHEMOTHERAPY AND PHARMACOLOGY

FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition

(2015) Zhijiao Zhou et al.   CANCER LETTERS

Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review

(2015) C.N. Frederiks et al.   CANCER TREATMENT REVIEWS

SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer

(2015) C. M. Della Corte et al.   CLINICAL CANCER RESEARCH

Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance

(2015) P Khongkow et al.   ONCOGENE

FOXM1 binds directly to non-consensus sequences in the human genome

(2015) Deborah A. Sanders et al.   GENOME BIOLOGY

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells

(2015) Wen-Tai Chiu et al.   Oncotarget

Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance

(2014) Fung Zhao et al.   PLoS One

HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction

(2014) Hyo Jin Kang et al.   Scientific Reports

Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells

(2013) Deborah A Sanders et al.   GENOME BIOLOGY

Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance

(2012) Xiaowei Zhang et al.   ANTI-CANCER DRUGS

Expression of Wnt3 Activates Wnt/ -Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells

(2012) Y. Wu et al.   MOLECULAR CANCER RESEARCH

Sonic Hedgehog Pathway Promotes Metastasis and Lymphangiogenesis via Activation of Akt, EMT, and MMP-9 Pathway in Gastric Cancer

(2011) Y. A. Yoo et al.   CANCER RESEARCH

FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy

(2011) Miranda S.C. Wilson et al.   CURRENT DRUG TARGETS

Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters

(2011) M Saxena et al.   Cell Death & Disease

The prevalence and prevention of nasopharyngeal carcinoma in China

(2011) Su-Mei Cao et al.   Chinese Journal of Cancer

FoxM1 Mediates Resistance to Herceptin and Paclitaxel

(2010) Janai R. Carr et al.   CANCER RESEARCH

Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma

(2009) Xia-Yun He et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

(2008) Swan Swan Leong et al.   CANCER

Association between multidrug resistance–associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapy

(2008) Noppadol Larbcharoensub et al.   HUMAN PATHOLOGY